We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Giving Back

Giving back has been a core element of our culture since our founding more than 40 years ago. We've built on that commitment over time, leveraging our resources, time and skills to drive change.

Today, our approach to giving is guided by our vision to improve the health and wellbeing of all patients, and create a future of science that is more diverse, inclusive and equitable.

We want to help create sustainable career pathways into the life sciences for students of color, address the root causes of disparities in our healthcare system and build more vibrant communities in the places where we live and work. These efforts enrich our longstanding commitment to positively impact science, patients and people.

We’re proud to be one of the top corporate philanthropists in the Bay Area for 16 consecutive years, and we continue to learn from our experiences to drive measurable impact for our communities. In 2020, we invested $90 million — our highest annual contribution to date — toward patient support, STEM education and health equity programs.

We’re also addressing systemic inequities in our society through partnerships with a wide range of organizations that focus on the issues facing our communities, from inequities in health and education to racial injustice.

We invite you to learn more about the ways we give back: